DUOCYCLINE LA 200MG/ML SOLUTION FOR INJECTION.
Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Tabia za bidhaa
(SPC)
03-06-2024
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
OXYTETRACYCLINE DIHYDRATE
Inapatikana kutoka:
Univet Limited
ATC kanuni:
QJ01AA06
INN (Jina la Kimataifa):
OXYTETRACYCLINE DIHYDRATE
Kipimo:
200 Mg/Ml
Dawa fomu:
Solution for Injection
Dawa ya aina:
POM
Kundi la matibabu:
Bovine, Ovine, Porcine
Eneo la matibabu:
Oxytetracycline
Matibabu dalili:
Antibacterial
Idhini hali ya:
Authorised
Idhini ya tarehe:
1988-10-01
Tabia za bidhaa
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Duocycline LA 200mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
A clear amber solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, sheep and pigs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
_Duocycline LA _is recommended in the treatment of a wide range of common systemic, respiratory and local infections
caused by, or associated with, organisms sensitive to Oxytetracycline.
4.3 CONTRAINDICATIONS
Do not use in sheep producing milk for human consumption.
Do not administer by the intravenous route.
Do not use in horses, dogs and cats.
Do not use in animals with known hypersensitivity to the active ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each ml contains:
ACTIVE SUBSTANCE
Oxytetracycline (as dihydrate)
200.0 mg
EXCIPIENTS
Sodium formaldehyde sulfoxylate
3.0 mg
For a full list of excipients, see section 6.1
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 23/10/2012_
_CRN 7011590_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible,
therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target
bacteria.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
This product contains dimethylacetamide (DMAC) and care should be taken to prevent absorption through the skin.
Wash hands after use.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Transient local reacti
Soma hati kamili
